Your browser doesn't support javascript.
loading
In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.
Worth, Heinrich; Buhl, Roland; Criée, Carl-Peter; Kardos, Peter; Gückel, Eva; Vogelmeier, Claus F.
Afiliación
  • Worth H; Facharztforum Fürth, 90762, Fürth, Germany. h.worth49@gmail.com.
  • Buhl R; Pulmonary Department, Mainz University Hospital, 55131, Mainz, Germany.
  • Criée CP; Department of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, 37120, Bovenden, Germany.
  • Kardos P; Group Practice and Centre for Allergy, Respiratory and Sleep Medicine, Red Cross Maingau Hospital, 60316, Frankfurt am Main, Germany.
  • Gückel E; Clinical Research, Respiratory, Novartis Pharma GmbH, 90429, Nürnberg, Germany.
  • Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), University Medical Centre Giessen and Marburg, Philipps-University Marburg, 35043, Marburg, Germany.
Respir Res ; 24(1): 2, 2023 Jan 05.
Article en En | MEDLINE | ID: mdl-36604646

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Eosinófilos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Respir Res Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Eosinófilos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Respir Res Año: 2023 Tipo del documento: Article País de afiliación: Alemania